Chemistry Holdings, Inc.

SANTA MONICA, CA · Founded 2016 · CIK 0001719091 · Biotech · Acquired

Generative AI system using GANs with medicinal chemist discriminators to design pharmaceutical compounds

chemistry.ai →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$845K
1 Form D · Oct 2017
108 months since last filing
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$844,998
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2576SUMOCOR, LLC——
2577Thiogenesis Therapeutics, Corp.—$878K
2578Gradient Pharmaceuticals, Inc.—$850K
2579Chemistry Holdings, Inc.—$845K
2580SOUTHEAST TECHINVENTURES, INC.—$836K
2581RAPHAEL PHARMACEUTICALS LLC——
2582KaloCyte Inc—$800K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 2 related persons
  • Rob DyrdekDirector
  • Joshua HeldDirector · Executive Officer · Promoter

Patents

USPTO · 0 granted of 1
  • Chemically Crosslinked Protein-polysaccharide Complexed Consumable Macrocapsuleapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.